Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-14

Clinical Trial Update: Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea (OSA) and Effect of 6-month CPAP Treatment [NA]

View source ↗

Summary

Clinical trial evaluating endothelial dysfunction, monocyte activation, and vasculopathy in obstructive sleep apnea and the impact of 6 months of CPAP therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Sleep Apnea, Obstructive, Continuous Positive Airway Pressure | NA | Status: UNKNOWN